A company with U.S. headquarters in Marlborough that was recently awarded FDA approval to sell its robotic exoskeletons for paraplegics plans to raise $50 million in an IPO this week, possibly on Friday.
Israeli-based ReWalk Robotics is planning to sell 3.5 million shares for between $14 and $16 each, which puts it at the low end of the 13 local health care companies which have gone public since the beginning of the year, more than any other year in history. Most of those have been biotech companies, however, making ReWalk the first robotics-focused company to do so in at least a couple of years.
Help employers find you! Check out all the jobs and post your resume.
